Buscar resultados de ensayos clínicos
Chronic Infantile Neurological Cutaneous Articular Syndrome - 8 Studies Found
Estado | Estudiar |
Terminated |
Nombre del estudio: Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease Condición:
Fecha: 2008-10-09 Intervenciones: Drug: Canakinumab |
Completed |
Nombre del estudio: Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Condición:
Intervenciones: Drug: Canakinumab (ACZ885) 6 mL glass vial containing 150 mg lyophilized Canakinumab reconstituted with |
Terminated |
Nombre del estudio: Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease Condición:
|
Completed |
Nombre del estudio: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease Condición:
Intervenciones: Drug: ACZ885 |
Completed |
Nombre del estudio: Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Condición:
Intervenciones: Drug: canakinumab canakinumab |
Terminated |
Nombre del estudio: HL2351 CAPS Phase II Study Condición: Cryopyrin‑Associated Periodic Syndromes (CAPS) Fecha: 2016-05-10 Intervenciones: Drug: HL2351 The dose will be adjusted based on disease activities |
Completed |
Nombre del estudio: The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada Condición: Cryopyrin Associated Periodic Syndrome Fecha: 2010-03-25 Intervenciones: Drug: canakinumab (company code: ACZ885D) |
Completed |
Nombre del estudio: Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients Condición:
|